$99.00
AOD-9604 is a modified peptide fragment of human growth hormone studied for its role in fat metabolism. It is widely researched for supporting lipolysis, inhibiting fat storage, and promoting metabolic efficiency.
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic peptide derived from the C-terminal fragment (176–191) of human growth hormone (hGH). It was specifically designed to target fat metabolism pathways without significantly influencing growth-related effects. Due to its focused mechanism, it has become a key compound in obesity and metabolic research.
AOD-9604 works by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage). It mimics the fat-reducing effects of growth hormone without activating pathways responsible for cell proliferation or insulin resistance in research models.
It acts on adipose tissue to increase the breakdown of stored fats into usable energy, while also limiting the accumulation of new fat.
This targeted mechanism makes it a focused compound for studying fat metabolism and energy balance.
AOD-9604 has been extensively studied in obesity and weight management research. It is particularly explored for its ability to promote fat loss without the broader systemic effects typically associated with full-length growth hormone.
Research also investigates its potential role in improving body composition and metabolic efficiency. Its selective action on fat metabolism pathways makes it a valuable compound in targeted metabolic studies.
Ongoing research continues to evaluate its broader applications in fat reduction and metabolic optimization.
Reviews
There are no reviews yet.